3 results
Not approvedWill not start
The primary objective is to study whether treatment with the mTOR inhibitor Everolimus results in an objectable change in phosphorylation of the selected downstream effectors 4eBP1 and p70S6K in human prostate cancer biopsies. A secondary objective…
Approved WMOCompleted
Purpose of this descriptive study is to gauge the feasibility of the Q1.6 app as platform to measure gout flares in real time. Primary research question: What is the perceived patients* value of thirty patients of app-based platform Q1.6 for…
Approved WMOPending
This study aims to evaluate IDRX-42 administered to participants with metastatic and/or surgically unresectable GIST.